Clinical efficacy analysis of natural orifice specimen extraction surgery (NOSES) and conventional laparoscopic surgery (CLS) in the treatment of rectal cancer: a single-center retrospective analysis - Takeaways - MDSpire

Clinical efficacy analysis of natural orifice specimen extraction surgery (NOSES) and conventional laparoscopic surgery (CLS) in the treatment of rectal cancer: a single-center retrospective analysis

  • By

  • Kai Deng

  • Yi-ran Li

  • Teng-long Guo

  • Jun-zhe Dou

  • Yu-liang Cui

  • Ying-feng Su

  • July 13, 2025

  • 0 min

Share

  • 1

    Colorectal cancer is the third most common cancer globally, necessitating effective surgical treatments to improve patient outcomes.

  • 2

    Natural orifice specimen extraction surgery (NOSES) offers a minimally invasive option for rectal cancer, potentially reducing postoperative pain and complications.

  • 3

    This study analyzed 221 rectal cancer patients, comparing outcomes between NOSES (24 patients) and conventional laparoscopic surgery (CLS, 197 patients).

  • 4

    Key treatment indicators evaluated included surgical time, blood loss, VAS scores, hospital stay, and complications to assess the efficacy of each surgical approach.

  • 5

    The study's findings aim to provide an evidence-based foundation for selecting surgical approaches in rectal cancer treatment.

Original Source(s)

Clinical efficacy analysis of natural orifice specimen extraction surgery (NOSES) and conventional laparoscopic surgery (CLS) in the treatment of rectal cancer: a single-center retrospective analysis

  • by Kai Deng, Yi-ran Li, Teng-long Guo, Jun-zhe Dou, Yu-liang Cui, Ying-feng Su

  • July 13, 2025

Related Content

Reduced Medicaid Retroactive Eligibility and Out-of-Pocket Costs for Patients With Gastrointestinal Cancer

Effects of home-based exercise on anxiety, depression, cancer-related fatigue, and quality of life in colorectal cancer patients: a meta-analysis of randomized controlled trials

Tracing the stemness and malignant transition in a heritable colorectal cancer Lynch Syndrome by single-cell RNA-seq analysis